Invasight
VerifiedA clinical biotech company that focused on revolutionizing cell invasion research
Launch date
Employees
Ownership
Firm valuation
$19—28m (Dealroom.co estimates Jun 2022.)
Zurich Canton of Zürich (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| $40k | Seed | ||
* | $4.7m | Seed | |
| Total Funding | $4.7m | ||